 |
|
Nicotine Found to Protect Against Parkinson's-Like Brain Damage
August 08, 2006New research suggests that nicotine treatment protects against the same type of brain damage that occurs in Parkinson's disease. The research was conducted in laboratory animals treated with MPTP, an agent that produces a gradual loss of brain function characteristic of Parkinson's. Experimental animals receiving chronic administration of nicotine over a period of six months had 25 percent less damage from the MPTP treatment than those not receiving nicotine.
This protective effect may explain the lower incidence of Parkinson's disease among smokers. The results also suggest that nicotine may be useful as a potential therapy in the treatment of early-stage Parkinson's patients.
The five-year study was conducted by researchers at The Parkinson's Institute, an independent, non-profit research institute located in Sunnyvale, California. The study results are published in an on-line early release in the Journal of Neurochemistry (doi:10.1111/j.1471-4159.2006.04078.x)
Parkinson's disease is a progressive, neurodegenerative disease caused by the death of small clusters of cells in the midbrain. The gradual loss of these cells results in reduction of a critical transmitter called dopamine, the chemical messenger responsible for normal movement.
"While we would never recommend that people smoke, these results suggest that nicotine promotes the survival of dopamine-producing cells in animals with no overt Parkinson's symptoms," said David A. Schwartz, M.D., director of the National Institute of Environmental Health Sciences, the federal agency that provided funding for the study. "These findings also have implications for its use in slowing the progression of Parkinson's."
Most of the research on tobacco has focused on its detrimental health effects. However, studies conducted over the last 40 years show that the incidence of Parkinson's disease is about 50 percent less in smokers than in the general population. "These studies were giving us clues that something in the smoke was reducing the incidence of Parkinson's," said Maryka Quik, Ph.D., a senior research scientist with The Parkinson's Institute and lead author on the study.
Based on these findings, the researchers wondered what compound in cigarette smoke could be causing this effect. "We decided to focus our attention on nicotine because studies have shown that nicotine stimulates the release of dopamine in the brain region that is associated with Parkinson's," said Quik.
To test their theory, the researchers treated experimental animals with MPTP, an agent that selectively destroys the dopamine-producing brain cells. Half of the animals also received a low-dose administration of nicotine over a six-month period. During this time, the nicotine dose was gradually increased to a level typically found in cigarette smoke.
The test results showed that animals receiving only the MPTP suffered a 75 percent loss of function in their dopamine-containing brain cells. When the researchers tested the animals that had received both MPTP and nicotine, the damage in the dopamine cells was only 50 percent. "The results suggested that the nicotine treatment had reduced the cell damage by 25 percent," said Quik.
While there is no immediate explanation for this effect, the researchers believe the nicotine may stimulate the release of naturally occurring proteins called growth factors that play a key role in nerve cell growth and repair. "It is also possible that the nicotine may activate the immune system to protect the cells from MPTP-induced damage," said Quik.
According to Quik, Parkinson's disease symptoms only start to develop when 80 to 90 percent of dopamine in striatal nerve terminals is depleted. "This means that a reduction in terminal damage from 80 to 60 percent can mean the difference between having disease symptoms and being symptom-free," said Quik.
While treatments currently available for Parkinson's disease are limited to the day to day relief of symptoms, nicotine may someday be used to reduce or even prevent the progression of the disease. "With current symptomatic therapies, the progress of the disease is not halted and, symptoms become worse and more difficult to control," said Quik. "With neuroprotection, a patient could receive treatment that would halt the disease progress and prevent symptoms from getting worse."
The Parkinson's Institute
Parkinson's disease is a progressive, neurodegenerative disease caused by the death of small clusters of cells in the midbrain. The gradual loss of these cells results in reduction of a critical transmitter called dopamine, the chemical messenger responsible for normal movement.
"While we would never recommend that people smoke, these results suggest that nicotine promotes the survival of dopamine-producing cells in animals with no overt Parkinson's symptoms," said David A. Schwartz, M.D., director of the National Institute of Environmental Health Sciences, the federal agency that provided funding for the study. "These findings also have implications for its use in slowing the progression of Parkinson's."
Most of the research on tobacco has focused on its detrimental health effects. However, studies conducted over the last 40 years show that the incidence of Parkinson's disease is about 50 percent less in smokers than in the general population. "These studies were giving us clues that something in the smoke was reducing the incidence of Parkinson's," said Maryka Quik, Ph.D., a senior research scientist with The Parkinson's Institute and lead author on the study.
Based on these findings, the researchers wondered what compound in cigarette smoke could be causing this effect. "We decided to focus our attention on nicotine because studies have shown that nicotine stimulates the release of dopamine in the brain region that is associated with Parkinson's," said Quik.
To test their theory, the researchers treated experimental animals with MPTP, an agent that selectively destroys the dopamine-producing brain cells. Half of the animals also received a low-dose administration of nicotine over a six-month period. During this time, the nicotine dose was gradually increased to a level typically found in cigarette smoke.
The test results showed that animals receiving only the MPTP suffered a 75 percent loss of function in their dopamine-containing brain cells. When the researchers tested the animals that had received both MPTP and nicotine, the damage in the dopamine cells was only 50 percent. "The results suggested that the nicotine treatment had reduced the cell damage by 25 percent," said Quik.
While there is no immediate explanation for this effect, the researchers believe the nicotine may stimulate the release of naturally occurring proteins called growth factors that play a key role in nerve cell growth and repair. "It is also possible that the nicotine may activate the immune system to protect the cells from MPTP-induced damage," said Quik.
According to Quik, Parkinson's disease symptoms only start to develop when 80 to 90 percent of dopamine in striatal nerve terminals is depleted. "This means that a reduction in terminal damage from 80 to 60 percent can mean the difference between having disease symptoms and being symptom-free," said Quik.
While treatments currently available for Parkinson's disease are limited to the day to day relief of symptoms, nicotine may someday be used to reduce or even prevent the progression of the disease. "With current symptomatic therapies, the progress of the disease is not halted and, symptoms become worse and more difficult to control," said Quik. "With neuroprotection, a patient could receive treatment that would halt the disease progress and prevent symptoms from getting worse."
The Parkinson's Institute
Nicotine News and Current Nicotine Events RSSK-State professor's research suggests that cigarettes' power may not be in nicotine itself
There may be a very good reason why coffee and cigarettes often seem to go hand in hand.
Smoking during pregnancy a 'double-edged sword' in SIDS
Premature infants whose mothers smoked during pregnancy may be at even higher risk for sudden infant death syndrome (SIDS) than preemies whose mothers did not smoke, according to new research out of the University of Calgary.
Newly-defined factors may prevent postpartum smoking relapse
Although many women quit smoking during pregnancy to protect their unborn children from the effects of cigarettes, half of them resume the habit within a few months of giving birth.
Poor sleep in teens linked to higher blood pressure
Teenagers are notorious for having bad sleep habits. New research suggests that having trouble staying awake the next day might not be the only consequence they face.
Caltech engineers build mini drug-producing biofactories in yeast
Researchers at the California Institute of Technology have developed a novel way to churn out large quantities of drugs, including antiplaque toothpaste additives, antibiotics, nicotine, and even morphine, using mini biofactories--in yeast.
If your first cigarette gave you a buzz and you now smoke, a gene may be to blame
Anyone who has ever tried smoking probably remembers that first cigarette vividly. For some, it brought a wave of nausea or a nasty coughing fit. For others, those first puffs also came with a rush of pleasure or "buzz."
Research reveals why some smokers become addicted with their first cigarette
New research from The University of Western Ontario reveals how the brain processes the 'rewarding' and addictive properties of nicotine, providing a better understanding of why some people seemingly become hooked with their first smoke.
Coffee and cigarette consumption are high among AA attendees
More than one million Americans currently participate in the Alcoholics Anonymous (AA) program. While AA participants are reportedly notorious for their coffee drinking and cigarette smoking, very little research has quantified their consumption of these two products.
Tobacco industry manipulated cigarette menthol content to recruit new smokers among young people
Menthol cigarette brands have been rising in popularity with adolescents, and the highest use has been among younger, newer smokers. Researchers at Harvard School of Public Health (HSPH) explored tobacco industry manipulation of menthol levels in specific brands and found a deliberate strategy to recruit and addict young smokers by adjusting menthol to create a milder experience for the first time smoker.
Prenatal drug exposure linked to sleep problems in children
In the first study across time into late childhood of the effects of prenatal drug exposure on sleep, prenatal drug exposure is associated with greater sleep problems in children.
More Nicotine News Articles
 | The Easy Way to Stop Smoking: Join the Millions Who Have Become Non-Smokers Using Allen Carr's Easyway Method by Allen Carr A new edition of the revolutionary bestseller, with four million copies in print. Allen Carr’s innovative Easyway method—which he discovered after his own 100-cigarette-a-day habit nearly drove him to despair—has helped millions kick smoking without feeling anxious and deprived. That’s because he helps smokers discover the psychological reasons behind their dependency,... |
 | The Little Book of Quitting by Allen Carr Allen Carr’s international bellseller, The Easy Way to Stop Smoking, has sold more than six million copies worldwide and helped to turn countless smokers into nonsmokers. The Little Book of Quitting crystallizes 120 key points of the Easyway™ method in a concise and readily accessible format. Carr’s method can enable any smoker to quit easily, painlessly, and permanently... |
| The Easy Way to Stop Smoking by Allen Carr This new edition of a revolutionary bestseller helps you use the Easyway method to eliminate the psychological reasons for smoking, handle withdrawal symptoms, avoid temptation situations, and stay a non-smoker! Discovered by Allen Carr in 1983 after his 100-cigarettes-a-day drove him to despair, this method is widely used around the world -- having helped millions of smokers quit successfully.... | |
 | Nicotine Dreams: A Story of Compulsive Gambling by Katie Cunningham Meet Kim, a fairly ordinary, middle-aged woman with a job, two adult children, and a difficult husband. For enjoyment she plays the stock market, buys expensive handbags and sneaks an occasional cigarette. But when a casino opens within driving distance of her house, her life as she knows it will soon be over. This is a story of addiction. This is a story of one woman's descent into gambling... |
 | Forever Smoke Free! Stop Smoking Hypnosis (3 CD Set) by Beverly Hills Hypnosis, Trevor H. Scott Our highly successful Stop Smoking Hypnosis Program consists of three stop smoking CDs. Stop Smoking Hypnosis Motivation, guides you through a series of relaxation techniques and suggestions, which will decrease your desire and increase your motivation to quit smoking - simply by listening to this relaxing hypnosis CD as you drift to sleep. At the end of this first week, you will listen to The... |
 | Recovery from Smoking: Quitting with the 12 Step Process by Elizabeth Hanson Hoffman, L.S.W., A.C.S.W., Christopher Douglas Hoffman Second Edition Elizabeth Hanson Hoffman rationalized her smoking for 27 years, then she finally accepted the fact that she was powerless over cigarettes. Using her own story, the Twelve Steps, and techniques she has developed as a practicing psychologist, Hoffman will help you find the strength to finally let go of... |
 | Nicotine Kiss: An Amos Walker Novel (Amos Walker Novels) by Loren D. Estleman Sometimes friendship is the only thing you can count on. Just before Thanksgiving, an old friend, cigarette smuggler Jeff Starzek, saved private detective Amos Walker’s life by getting him to the hospital when he was shot. After New Year’s, Walker gets a frantic call from Starzek’s sister. Jeff’s missing; hasn’t been in touch for weeks. It’s just not like... |
 | The Tao Of Quitting Smoking by Joseph P. Weaver A spiritual guide to quitting smoking without gaining weight! Most fail when attempting to quit smoking because they forget about dealing with the whole. Addiction is not only physical but also psychological. This is not just another "quit smoking" book--it is about self-discovery, the key element to freeing yourself of the fear of failing one more time. With self-awareness and the knowledge... |
 | Stop Smoking Forever by Glenn Harrold Stop smoking forever with this superb high quality hypnosis CD by Glenn Harrold. Hypnotherapy is uniquely effective in programming the mind to overcome the addiction to cigarettes and nicotine in a safe and natural way, free of any harmful side effects. When you listen to this quit smoking hypnotherapy tape/CD title your mind will very quickly get used to the idea that you don't smoke, and as... |
 | Quit Smoking Now! A doctor designed, truly effective smoking cessation program... (Boomer Book Series) by M.D. Othniel Seiden, Ph.D. Jane L. Bilett "Smoking / Tobacco use is an addiction!" Smoking is an addiction to the chemical substance Nicotine. Nicotine addiction is considered by many authorities to be as strong as an addiction to heroin or opium. That being the case, now is the best time to quit because tomorrow your addiction will be stronger. Doctors to the World is sponsoring this program in support of their initiative to... |
| © 2008 BrightSurf.com |